Cargando…
RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers
Adamson et al. report that BRCA2 mutation carriers inheriting RAD52 S346X variant have reduced breast cancer risk. The RAD52 S346X variant lacks the nuclear localization sequence, which mislocalizes the protein to the cytoplasm and renders it nonfunctional. Combined loss of BRCA2‐mediated DNA repair...
Autores principales: | Biswas, Kajal, Sharan, Shyam K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266267/ https://www.ncbi.nlm.nih.gov/pubmed/32255263 http://dx.doi.org/10.1002/1878-0261.12679 |
Ejemplares similares
-
The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations
por: Adamson, Aaron W., et al.
Publicado: (2020) -
Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008) -
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999) -
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
Publicado: (2007) -
RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
por: Rachner, Tilman D., et al.
Publicado: (2015)